Stress Echocardiography-Derived E/e’ Predicts Abnormal Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction

Stress Echocardiography-Derived E/e’ Predicts Abnormal Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction

BackgroundThe correlation between echocardiographic parameters and hemodynamics data in patients with heart failure with preserved ejection fraction (HFpEF) is unclear. It is important to find a non-invasive echocardiographic parameter for predicting exercise pulmonary capillary wedge pressure (PCWP...

Full description

Bibliographic Details
Main Authors:	Zheng-Wei Chen, Chen-Yu Huang, Jen-Fang Cheng, Ssu-Yuan Chen, Lian-Yu Lin, Cho-Kai Wu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-12-01
Series:	Frontiers in Physiology
Subjects:	HFpEF stress Doppler echocardiography hemodynamics GLS tissue Doppler and strain echocardiography
Online Access:	https://www.frontiersin.org/article/10.3389/fphys.2019.01470/full

Similar Items

Antiphospholipid Antibodies and Heart Failure with Preserved Ejection Fraction. The Multicenter ATHERO-APS Study
by: Daniele Pastori, et al.
Published: (2021-07-01)

Deleterious Effects of Epicardial Adipose Tissue Volume on Global Longitudinal Strain in Patients With Preserved Left Ventricular Ejection Fraction
by: Gulinu Maimaituxun, et al.
Published: (2021-01-01)

Different determinants of exercise capacity in HFpEF compared to HFrEF
by: Arlind Batalli, et al.
Published: (2017-04-01)

Novel pathways of heart failure with preserved ejection fraction
by: Li, Shanpeng
Published: (2016)

Comparison of global and regional myocardial strains in patients with heart failure with a preserved ejection fraction vs hypertension vs age-matched control
by: Hyung Yoon Kim, et al.
Published: (2020-11-01)

Impact of severe obesity on exercise performance in heart failure with preserved ejection fraction
by: Satyam Sarma, et al.
Published: (2020-11-01)

Approach to the Treatment of Heart Failure With Preserved Ejection Fraction and Mid-Range Ejection Fraction
by: Ewa A Jankowska, et al.
Published: (2017-01-01)

Murine Models of Heart Failure With Preserved Ejection Fraction
by: Maria Valero-Muñoz, PhD, et al.
Published: (2017-12-01)

Optimizing the discovery and assessment of therapeutic targets in heart failure with preserved ejection fraction
by: Gabrielle Fusco‐Allison, et al.
Published: (2021-10-01)

Prognostic significance of the HFA‐PEFF score in patients with heart failure with preserved ejection fraction
by: Yohei Sotomi, et al.
Published: (2021-06-01)

Heart Failure: The Dilemma of the 40-50% Ejection Fraction Range
by: Michael Henein, et al.
Published: (2017-01-01)

Multimodality assessment of heart failure with preserved ejection fraction skeletal muscle reveals differences in the machinery of energy fuel metabolism
by: Payman Zamani, et al.
Published: (2021-08-01)

Prognostic relevance of elevated plasma osmolality on admission in acute decompensated heart failure with preserved ejection fraction: insights from PURSUIT-HFpEF registry
by: Akito Nakagawa, et al.
Published: (2021-06-01)

Myths and Facts About Heart Failure with Preserved Ejection Fraction: Risk Factors, Longevity, Potential Pharmacological and Exercise Interventions
by: Chung-Lieh Hung, et al.
Published: (2013-03-01)

Weight Change and Mortality Risk in Heart Failure With Preserved Ejection Fraction
by: Peisen Huang, et al.
Published: (2021-06-01)

Stratified Treatment of Heart Failure with preserved Ejection Fraction: rationale and design of the STADIA‐HFpEF trial
by: Mariëlle Scheffer, et al.
Published: (2020-12-01)

Hydrogen Sulfide as a Potential Therapy for Heart Failure—Past, Present, and Future
by: Kyle B. LaPenna, et al.
Published: (2021-03-01)

Leucocyte count predicts cardiovascular risk in heart failure with preserved ejection fraction: insights from TOPCAT Americas
by: Navkaranbir S. Bajaj, et al.
Published: (2020-08-01)

The controlling nutritional status score predicts outcomes of cardiovascular events in patients with heart failure with preserved ejection fraction
by: Takashi Komorita, et al.
Published: (2020-08-01)

Exosomal microRNAs miR-30d-5p and miR-126a-5p Are Associated with Heart Failure with Preserved Ejection Fraction in STZ-Induced Type 1 Diabetic Rats
by: Chang, C.-C, et al.
Published: (2022)

The Management of Heart Failure with Preserved Ejection Fraction (HFpEF)
by: Andrew J Stewart Coats, et al.
Published: (2014-01-01)

Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
by: Mark Sweeney, et al.
Published: (2020-10-01)

Sex and Heart Failure with Preserved Ejection Fraction: From Pathophysiology to Clinical Studies
by: Marijana Tadic, et al.
Published: (2019-06-01)

Heart Failure with Preserved Ejection Fraction (HFpEF): A Case Report
by: Amanda Halimi, et al.
Published: (2021-09-01)

Inhalation of Ultrafine Zinc Particles Impaired Cardiovascular Functions in Hypertension-Induced Heart Failure Rats With Preserved Ejection Fraction
by: Fangbo Bing, et al.
Published: (2020-01-01)

Large Animal Models of Heart Failure: Reduced vs. Preserved Ejection Fraction
by: Christopher J. Charles, et al.
Published: (2020-10-01)

Leukocyte count and the risk of adverse outcomes in patients with HFpEF
by: Zhaowei Zhu, et al.
Published: (2021-07-01)

Real‐world clinical diagnostics of heart failure patients with reduced or preserved ejection fraction
by: Jenni Huusko, et al.
Published: (2020-06-01)

Skeletal Muscle Microvascular Dysfunction Manifests Early in Diabetic Cardiomyopathy
by: Sadi Loai, et al.
Published: (2021-07-01)

Independent predictors of developing pulmonary hypertension in heart failure with reduced versus preserved ejection fraction
by: Alaa Roushdy, et al.
Published: (2017-07-01)

Growth differentiation factor 15 as mortality predictor in heart failure patients with non‐reduced ejection fraction
by: Ana Belen Mendez Fernandez, et al.
Published: (2020-10-01)

Effects of different exercise modalities on cardiac dysfunction in heart failure with preserved ejection fraction
by: David Bode, et al.
Published: (2021-06-01)

Clinical phenogroups are more effective than left ventricular ejection fraction categories in stratifying heart failure outcomes
by: Andreas B. Gevaert, et al.
Published: (2021-08-01)

A composite metric for predicting benefit from spironolactone in heart failure with preserved ejection fraction
by: Mark N. Belkin, et al.
Published: (2021-10-01)

Variation in clinical and patient‐reported outcomes among complex heart failure with preserved ejection fraction phenotypes
by: Kelsey M. Flint, et al.
Published: (2020-06-01)

Plasma trimethylamine n-oxide is associated with renal function in patients with heart failure with preserved ejection fraction
by: Fei Guo, et al.
Published: (2020-08-01)

Heart Failure With Preserved Ejection Fraction and Obesity
by: Arjun Sinha, MD, et al.
Published: (2020-01-01)

Baseline characteristics of patients with heart failure and preserved ejection fraction at admission with acute heart failure in Saudi Arabia
by: Samah Abohammar, et al.
Published: (2017-03-01)

Predictors of long‐term outcome in heart failure with preserved ejection fraction: a follow‐up from the KaRen study
by: Angiza Shahim, et al.
Published: (2021-10-01)

Circulating neuregulin1‐β in heart failure with preserved and reduced left ventricular ejection fraction
by: Camilla Hage, et al.
Published: (2020-04-01)